Crossmark

Esmolol infusion in patients with septic shock and tachycardia: a prospective, single-arm, feasibility study

Crossref DOI link: https://doi.org/10.1186/s40814-018-0321-5

Published Online: 2018-08-03

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Brown, Samuel M. http://orcid.org/0000-0003-1206-6261
Beesley, Sarah J.

Lanspa, Michael J.

Grissom, Colin K.

Wilson, Emily L.

Parikh, Samir M.

Sarge, Todd

Talmor, Daniel

Banner-Goodspeed, Valerie

Novack, Victor

Thompson, B. Taylor

Shahul, Sajid
License Information

Text and Data Mining valid from 2018-08-03
More Information

Article History

Received: 9 August 2017

Accepted: 17 July 2018

First Online: 3 August 2018

Ethics approval and consent to participate

: This study was approved by the Intermountain Medical Center Institutional Review Board (1050147). Written informed consent was obtained from all patients or their legally authorized representatives.

: NA.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.